163 related articles for article (PubMed ID: 16904437)
1. Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas.
Gao B; Meng F; Bian W; Chen J; Zhao H; Ma G; Shi B; Zhang J; Liu Y; Xu Z
Urology; 2006 Aug; 68(2):282-6. PubMed ID: 16904437
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of Pheochromocytoma of the Adrenal Gland Scaled Score (Pass score) tests to separate benign from malignant neoplasms.
Mlika M; Kourda N; Zorgati MM; Bahri S; Ben Ammar S; Zermani R
Tunis Med; 2013 Mar; 91(3):209-15. PubMed ID: 23588637
[TBL] [Abstract][Full Text] [Related]
3. Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling.
Suh I; Shibru D; Eisenhofer G; Pacak K; Duh QY; Clark OH; Kebebew E
Ann Surg; 2009 Dec; 250(6):983-90. PubMed ID: 19661783
[TBL] [Abstract][Full Text] [Related]
4. A logistic regression model for predicting malignant pheochromocytomas.
Gao B; Sun Y; Liu Z; Meng F; Shi B; Liu Y; Xu Z
J Cancer Res Clin Oncol; 2008 Jun; 134(6):631-4. PubMed ID: 17999082
[TBL] [Abstract][Full Text] [Related]
5. Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score.
Wu D; Tischler AS; Lloyd RV; DeLellis RA; de Krijger R; van Nederveen F; Nosé V
Am J Surg Pathol; 2009 Apr; 33(4):599-608. PubMed ID: 19145205
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract][Full Text] [Related]
7. A comparison of regression trees, logistic regression, generalized additive models, and multivariate adaptive regression splines for predicting AMI mortality.
Austin PC
Stat Med; 2007 Jul; 26(15):2937-57. PubMed ID: 17186501
[TBL] [Abstract][Full Text] [Related]
8. Combining early coagulation and inflammatory status improves prediction of mortality in burned and nonburned trauma patients.
Park MS; Salinas J; Wade CE; Wang J; Martini W; Pusateri AE; Merrill GA; Chung K; Wolf SE; Holcomb JB
J Trauma; 2008 Feb; 64(2 Suppl):S188-94. PubMed ID: 18376164
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for malignant pheochromocytoma: analysis of 136 patients.
Feng F; Zhu Y; Wang X; Wu Y; Zhou W; Jin X; Zhang R; Sun F; Kasoma Z; Shen Z
J Urol; 2011 May; 185(5):1583-90. PubMed ID: 21419457
[TBL] [Abstract][Full Text] [Related]
10. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.
Hu MY; Katchar K; Kyne L; Maroo S; Tummala S; Dreisbach V; Xu H; Leffler DA; Kelly CP
Gastroenterology; 2009 Apr; 136(4):1206-14. PubMed ID: 19162027
[TBL] [Abstract][Full Text] [Related]
11. [The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas].
Feng C; Li HZ; Yan WG; Gao JG; Xu WF; Luo YF; Cao JL
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1697-700. PubMed ID: 18476530
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models.
Mol BW; Boll D; De Kanter M; Heintz AP; Sijmons EA; Oei SG; Bal H; Brölmann HA
Gynecol Oncol; 2001 Feb; 80(2):162-7. PubMed ID: 11161854
[TBL] [Abstract][Full Text] [Related]
13. Development of differential diagnosis for benign and malignant pheochromocytomas.
Gao B; Kong F; Xu Z
Int J Urol; 2008 Sep; 15(9):771-7. PubMed ID: 18651863
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.
Perry CG; Sawka AM; Singh R; Thabane L; Bajnarek J; Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):703-8. PubMed ID: 17388796
[TBL] [Abstract][Full Text] [Related]
15. Morphometric analysis of benign and malignant adrenal pheochromocytomas.
Hoffman K; Gil J; Barba J; Liu Z; Pertsemlidis D; Kaneko M; Unger P
Arch Pathol Lab Med; 1993 Mar; 117(3):244-7. PubMed ID: 8442669
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a risk score for post-infectious irritable bowel syndrome.
Thabane M; Simunovic M; Akhtar-Danesh N; Marshall JK
Am J Gastroenterol; 2009 Sep; 104(9):2267-74. PubMed ID: 19568228
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases.
Thompson LD
Am J Surg Pathol; 2002 May; 26(5):551-66. PubMed ID: 11979086
[TBL] [Abstract][Full Text] [Related]
18. Base deficit-based predictive modeling of outcome in trauma patients admitted to intensive care units in Dutch trauma centers.
Kroezen F; Bijlsma TS; Liem MS; Meeuwis JD; Leenen LP
J Trauma; 2007 Oct; 63(4):908-13. PubMed ID: 18090025
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in gastrointestinal bleeding due to peptic ulcer: construction of a predictive model.
Zaragoza AM; Tenías JM; Llorente MJ; Alborch A
J Clin Gastroenterol; 2008 Aug; 42(7):786-90. PubMed ID: 18580501
[TBL] [Abstract][Full Text] [Related]
20. Predictive model of antimicrobial-resistant gram-negative bacteremia at the ED.
Chiang WC; Chen SY; Chien KL; Wu GH; Yen AM; Su CP; Lee CC; Chen YC; Chang SC; Chen SC; Chen WJ; Chen TH
Am J Emerg Med; 2007 Jul; 25(6):597-607. PubMed ID: 17606081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
